Risperidone and the 5‐HT2A Receptor Antagonist M 100907 Improve Probabilistic Reversal Learning in BTBR T + tf/J Mice
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interactions with restricted interests and repetitive behaviors (RRBs). RRBs can severely limit daily living and be particularly stressful to family members. To date, there are limited options for treating this feature in ASD. Risperidone, an atypical antipsychotic, is approved to treat irritability in ASD, but less is known about whether it is effective in treating “higher order” RRBs, for example cognitive inflexibility. Risperidone also has multiple receptor targets in which only a subset may be procognitive and others induce cognitive impairment. 5HT 2A receptor blockade represents one promising and more targeted approach, as various preclinical studies have shown that 5HT 2A receptor antagonists improve cognition. The present study investigated whether risperidone and/or M 100907, a 5HT 2A receptor antagonist, improved probabilistic reversal learning performance in the BTBR T + tf/J (BTBR) mouse model of autism. The effects of these treatments were also investigated in C57BL/6 J (B 6) mice as a comparison strain. Using a spatial reversal learning test with 80/20 probabilistic feedback, similar to one in which ASD individuals exhibit impairments, both risperidone (0.125 mg) and M 100907 (0.01 and 0.1 mg) improved reversal learning in BTBR mice. Risperidone (0.125 mg) impaired reversal learning in B 6 mice. Improvement in probabilistic reversal learning performance resulted from treatments enhancing the maintenance of the newly correct choice pattern. Because risperidone can lead to unwanted side effects, treatment with a specific 5HT 2A receptor antagonist may improve cognitive flexibility in individuals with ASD while also minimizing unwanted side effects. Autism Res 2014, 7: 555–567. © 2014 International Society for Autism Research, Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 1×
“Autism spectrum disorder (ASD) is a persistent neurodevelopmental disorder characterized by both deficits in social communication and the presence of repetitive and restricted behaviors (RRBs) [Bodfish, Symons, Parker, & Lewis, 2000; Fombonne, 2009; Rapin & Tuchman, 2008].”
BackgroundExecutive function deficits in high-functioning autistic individuals: Relationship to theory of mind
Ozonoff, S., Pennington, B. F., & Rogers, S. J. (1991) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1991.tb00351.x · Cited by 1,766
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Varieties of Repetitive Behavior in Autism: Comparisons to Mental Retardation
Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M. H. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005596502855 · Cited by 1,223
Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075 · cited 1×
“The present results with risperidone are also comparable to those in which mice with a knockout of the CNTNAP2 gene, which is associated with ASD, exhibited behavioral flexibility impairments that were attenuated by acute risperidone treatment [Peñagarikano et al., 2011].”
ResultPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Autism‐like behavioral phenotypes in BTBR T+tf/J mice
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812 · cited 2×
“…related to ASD because the mouse exhibits social deficits, as well as repetitive behaviors, for example, increased selfgrooming and marble burying [Amodeo, Jones, Sweeney, & Ragozzino, 2012; McFarlane et al., 2008; Moy et al., 2008; Pearson et al., 2011; Pobbe et al., 2010; Yang et al., 2007].”
BackgroundLam, K. S. L., & Aman, M. G. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0213-z · Cited by 793
Brief Report: Specific Executive Function Profiles in Three Neurodevelopmental Disorders
Ozonoff, S., & Jensen, J. (1999) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1023052913110 · Cited by 724 · cited 2×
“…studies have used the Wisconsin Card Sorting Task (WCST) to determine whether ASD individuals exhibit cognitive flexibility impairments [Memari et al., 2013; Ozonoff & Jensen, 1999; Pooragha, Kafi, & Sotodeh, 2013; Robinson, Goddard, Dritschel, Wisley, & Howlin, 2009; Williams & Jarrold, 2013].”
BackgroundMethodMarble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L. A., & Paylor, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1466-y · Cited by 698 · cited 1×
“These findings in BTBR mice expand on past studies demonstrating that risperidone treatment decreased repetitive self-grooming [Silverman et al., 2010] and reduced marble burying [Gould et al., 2011; Thomas et al., 2009], both measures of repetitive behavior.”
BackgroundDias, R., Robbins, T. W., & Roberts, A. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09285.1997 · Cited by 555
Chudasama, Y., & Robbins, T. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08771.2003 · Cited by 543
The paradox of cognitive flexibility in autism
Geurts, H. M., Corbett, B., & Solomon, M. (2009) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2008.11.006 · Cited by 538 · cited 2×
“…to cognitive inflexibility, successful task performance requires several processes, including feedback incorporation, appropriate strategy detection, response inhibition, and maintenance of newly appropriate response patterns following switches that occur throughout testing [Geurts et al., 2009].”
BackgroundInfluentialRAGOZZINO, M. E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1401.013 · Cited by 482
Self-citationAman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
Floresco, S. B., Magyar, O., Ghods-Sharifi, S., Vexelman, C., & Tse, M. T. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300825 · Cited by 395 · cited 2×
“Past studies in both healthy humans and rodents revealed that administration of a selective dopamine D2 receptor antagonist impairs reversal learning and set-shifting performance [De Steno & Schmauss, 2009; Floresco et al., 2006; Mehta, Manes, Magnolfi, Sahakian, & Robbins, 2004; Mehta, Sahakian, McKenna, & Robbins, 1…”
BackgroundSutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392 · cited 1×
“The 5HT transporter gene Ala56 variant confers risk in ASD and has been associated with compulsive behaviors [Sutcliffe et al., 2005].”
BackgroundA Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0427 · Cited by 356 · cited 3×
“The complex pharmacology of a drug like risperidone, while potentially having procognitive effects, may also lead to severe and unwanted side effects, for example, weight gain and sedation [Aman, De Smedt, Derivan, Lyons, & Findling, 2002; Dove et al., 2012; Findling et al., 2000; McPheeters et al., 2011; Rummel-Kluge…”
BackgroundBlood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis
Gabriele, S., Sacco, R., & Persico, A. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.004 · Cited by 346
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333 · cited 3×
“Investigations into specific biomarkers for ASD have consistently shown elevated blood 5HT levels or hyperserotonemia in approximately 30% of ASD individuals [Cook & Leventhal, 1996; Gabriele, Sacco, & Persico, 2014; Veenstra-VanderWeele et al., 2012].”
BackgroundHollander, E., Soorya, L., Chaplin, W., Anagnostou, E., Taylor, B. P., Ferretti, C. J., Wasserman, S., Swanson, E., & Settipani, C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10050764 · Cited by 224
Mehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051102 · Cited by 223
Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., & Minderaa, R. B. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200404000-00016 · Cited by 199
Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat
Tait, D. S., Brown, V. J., Farovik, A., Theobald, D. E., Dalley, J. W., & Robbins, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05612.x · Cited by 179
Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism
Pearson, B. L., Pobbe, R. L. H., Defensor, E. B., Oasay, L., Bolivar, V. J., Blanchard, D. C., & Blanchard, R. J. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00659.x · Cited by 171 · cited 2×
“…related to ASD because the mouse exhibits social deficits, as well as repetitive behaviors, for example, increased selfgrooming and marble burying [Amodeo, Jones, Sweeney, & Ragozzino, 2012; McFarlane et al., 2008; Moy et al., 2008; Pearson et al., 2011; Pobbe et al., 2010; Yang et al., 2007].”
BackgroundLow stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism
Silverman, J. L., Yang, M., Turner, S. M., Katz, A. M., Bell, D. B., Koenig, J. I., & Crawley, J. N. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.059 · Cited by 146
Yang, M. (2007) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.001.2007 · Cited by 124
Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review
Dove, D., Warren, Z., McPheeters, M. L., Taylor, J. L., Sathe, N. A., & Veenstra-VanderWeele, J. (2012) · Pediatrics · doi:10.1542/peds.2012-0683 · Cited by 115 · cited 2×
“The complex pharmacology of a drug like risperidone, while potentially having procognitive effects, may also lead to severe and unwanted side effects, for example, weight gain and sedation [Aman, De Smedt, Derivan, Lyons, & Findling, 2002; Dove et al., 2012; Findling et al., 2000; McPheeters et al., 2011; Rummel-Kluge…”
BackgroundProbabilistic reinforcement learning in adults with autism spectrum disorders
Solomon, M., Smith, A. C., Frank, M. J., Ly, S., & Carter, C. S. (2011) · Autism Research · doi:10.1002/aur.177 · Cited by 97
Psychopharmacology in autism: an update
Canitano, R., & Scandurra, V. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.015 · Cited by 79
Furr, A., Lapiz-Bluhm, M. D., & Morilak, D. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001441 · Cited by 74
Brown, H. D., Amodeo, D. A., Sweeney, J. A., & Ragozzino, M. E. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430749 · Cited by 56 · cited 1×
“Moreover, SSRI treatment improves probabilistic reversal learning in rats by reducing regressive errors [Brown et al., 2012].”
BackgroundSelf-citationKaland, N., Mortensen, E. L., & Smith, L. (2007) · Autism · doi:10.1177/1362361307070988 · Cited by 54
Lesions of the dorsomedial striatum impair formation of attentional set in rats
Lindgren, H. S., Wickens, R., Tait, D. S., Brown, V. J., & Dunnett, S. B. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.034 · Cited by 49
Cited by
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
“Drugs targeting serotonin receptors, particularly 5-HT1A and 5-HT2A, have shown promise for increasing social interaction or decreasing cognitive rigidity (File et al., 1996, Edwards et al., 2006, Boulougouris and Robbins, 2010, Gould et al., 2011, Amodeo et al., 2014).”
BackgroundExcitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders
Lee, E., Lee, J., & Kim, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.011 · Cited by 468
The role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 382
Doss, M. K., Považan, M., Rosenberg, M. D., Sepeda, N. D., Davis, A. K., Finan, P. H., Smith, G. S., Pekar, J. J., Barker, P. B., Griffiths, R. R., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01706-y · Cited by 356
Miller, H. L., Ragozzino, M. E., Cook, E. H., Sweeney, J. A., & Mosconi, M. W. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2244-1 · Cited by 131
Self-citation
Metadata
- Authors
- Amodeo, D. A., Jones, J. H., Sweeney, J. A., & Ragozzino, M. E.
- Venue
- Autism Research
- Publisher
- Wiley
- Published
- 2014-06-03
- Volume
- 7
- Issue
- 5
- Pages
- 555-567
- ISSN
- 1939-3792 (ISSN-L)
- 1939-3806
- OpenAlex
- W1601302239
- Cited by
- 79
- References
- 35
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.